Recent research demonstrates that individuals harboring BRCA2 mutations have a higher risk of developing male breast cancer, prostate cancer, and pancreatic cancer than those with BRCA1 mutations [72]. This evidence concerns the gene BRCA1 and prostate carcinoma.